Get started
Author

Jin Matsuyama

Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial
2019 · Kazuhiro Yoshida, Yasuhiro Kodera, et al. · Journal of Clinical Oncology · 394
Effects of an Oral Elemental Nutritional Supplement on Post-gastrectomy Body Weight Loss in Gastric Cancer Patients: A Randomized Controlled Clinical Trial
2016 · Hiroshi Imamura, Kazuhiro Nishikawa, et al. · Annals of Surgical Oncology · 105
Multicenter prospective trial of total gastrectomy versus proximal gastrectomy for upper third cT1 gastric cancer
2020 · Makoto Yamasaki, S. Takiguchi, et al. · Gastric Cancer · 72
PDF
Multicentre biomarker cohort study on the efficacy of nivolumab treatment for gastric cancer
2020 · Takaomi Hagi, Yukinori Kurokawa, et al. · British Journal of Cancer · 71
PDF
Oral nutritional supplements versus a regular diet alone for body weight loss after gastrectomy: a phase 3, multicenter, open-label randomized controlled trial
2021 · Yasuhiro Miyazaki, Takeshi Omori, et al. · Gastric Cancer · 69
PDF
The effect of neoadjuvant chemotherapy on lymph node micrometastases in squamous cell carcinomas of the thoracic esophagus
2007 · Jin Matsuyama, Yuichiro Doki, et al. · Surgery · 64
The activation of Akt during preoperative chemotherapy for esophageal cancer correlates with poor prognosis
2008 · Akiko Yoshioka, Hiroshi Miyata, et al. · Oncology Reports · 56
PDF
Clinical Outcome and Indications for Palliative Gastrojejunostomy in Unresectable Advanced Gastric Cancer: Multi-Institutional Retrospective Analysis
2013 · Atsushi Takeno, Shuji Takiguchi, et al. · Annals of Surgical Oncology · 50
Long‐term effects of an oral elemental nutritional supplement on post‐gastrectomy body weight loss in gastric cancer patients (KSES002)
2019 · Yutaka Kimura, Kazuhiro Nishikawa, et al. · Annals of Gastroenterological Surgery · 49
PDF
p53 Genotype Predicts Response to Chemotherapy in Patients with Squamous Cell Carcinoma of the Esophagus
2009 · Makoto Yamasaki, Hiroshi Miyata, et al. · Annals of Surgical Oncology · 46
Correlation between tumor blood flow assessed by perfusion CT and effect of neoadjuvant therapy in advanced esophageal cancers
2007 · Yoichi Makari, Takushi Yasuda, et al. · Journal of Surgical Oncology · 42
Real-world effectiveness of nivolumab in advanced gastric cancer: the DELIVER trial (JACCRO GC-08)
2021 · Yoshikazu Takahashi, Yu Sunakawa, et al. · Gastric Cancer · 35
PDF
Three-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy
2013 · Kazumasa Fujitani, Shigeyuki Tamura, et al. · Gastric Cancer · 32
PDF
A randomized phase III study comparing S-1 plus docetaxel with S-1 alone as a postoperative adjuvant chemotherapy for curatively resected stage III gastric cancer (JACCRO GC-07 trial).
2018 · Yasuhiro Kodera, Kazuhiro Yoshida, et al. · Journal of Clinical Oncology · 30
Genomic pathway of gut microbiome to predict efficacy of nivolumab in advanced gastric cancer: DELIVER trial (JACCRO GC-08).
2021 · Yu Sunakawa, Ryo Matoba, et al. · Journal of Clinical Oncology · 25
Evaluation of clinical significance of18F-fluorodeoxyglucose positron emission tomography in superficial squamous cell carcinomas of the thoracic esophagus
2007 · H. Miyata, Y. Doki, et al. · Diseases of the Esophagus · 25
Effects of an oral elemental nutritional supplement in gastric cancer patients with adjuvant S‐1 chemotherapy after gastrectomy: A multicenter, open‐label, single‐arm, prospective phase II study (OGSG1108)
2021 · Hiroshi Imamura, Jin Matsuyama, et al. · Annals of Gastroenterological Surgery · 23
PDF
Soluble programmed cell death ligand 1 predicts prognosis for gastric cancer patients treated with nivolumab: Blood-based biomarker analysis for the DELIVER trial
2023 · Hisato Kawakami, Yu Sunakawa, et al. · European Journal of Cancer · 22
Comparison of 5‐year postoperative outcomes after Billroth I and Roux‐en‐Y reconstruction following distal gastrectomy for gastric cancer: Results from a multi‐institutional randomized controlled trial
2020 · Yutaka Kimura, Jota Mikami, et al. · Annals of Gastroenterological Surgery · 21
PDF
A case of completely isolated advanced enteric duplication cyst cancer performed partial pancreatectomy
2018 · Shinsuke Nakashima, Terumasa Yamada, et al. · International Journal of Surgery Case Reports · 19
PDF
Real-world effectiveness of third- or later-line treatment in Japanese patients with HER2-positive, unresectable, recurrent or metastatic gastric cancer: a retrospective observational study
2022 · Daisuke Sakai, Takeshi Omori, et al. · International Journal of Clinical Oncology · 17
PDF
Prognostic factors for cytology-positive gastric cancer
2018 · Shunji Endo, Masakazu Ikenaga, et al. · Surgery Today · 17
A Phase II Study of Perioperative Capecitabine plus Oxaliplatin Therapy for Clinical SS/SE N1-3 M0 Gastric Cancer (OGSG 1601)
2019 · Tetsuji Terazawa, Jin Matsuyama, et al. · The Oncologist · 15
PDF
Phase II Feasibility Study of Adjuvant S-1 plus Docetaxel for Stage III Gastric Cancer Patients after Curative D2 Gastrectomy
2011 · Shigeyuki Tamura, Kazumasa Fujitani, et al. · Oncology · 15
Mucoepidermoid carcinoma of the esophagus treated by endoscopic mucosal resection
2003 · S. Tamura, K. Kobayashi, et al. · Diseases of the Esophagus · 15
Works count: 205
Citation count: 1,650
H-index: 19
I10-index: 33
Year
Topic
Type